Health Highlights

Automatically Generated - Will be deleted after first publication of article.
New Diet drug may have heart-risk studies: FDA
New anti-obesity drugs may need to undergo studies to evaluate potential risks hearts before they are approved for sale in the United States, according to a Food and Drug Administration evaluation.
Outside experts advising the FDA soon by three California-based applications for the first weight loss pills available in the U.S. market will be launched in 13 years, told Bloomberg News.
Are the experts, whether considered "obese without a theoretical risk, or a signal for" potential damage to the heart "should be required to be excluded," a measure of cardiovascular risk before approval, said the FDA staff report.
The latest obesity drug was approved by the FDA in 1999, Xenical. Fifteen years ago, the fen-phen combination of appetite suppression drug was pulled from the market after it was linked to heart valve problems, reported Bloomberg.
-----
The production at three plants that make 'Pink Slime Suspended'
The company that makes a product as well beef "pink slime" called stopped production at all from one plant to a sharp decline in the economy stemming from a recent public uproar.
Beef Products Inc. has suspended operations at plants in Amarillo, Texas, Garden City, Kansas, and Waterloo, Iowa. The plant in Dakota Dunes, S.D. continue the production, the Associated Press reported.
The company's sales of what "beef lean, finely textured" in the industry as crashed known for a social media eruption of concern over the ammonia-treated filler and hundreds of thousands of people signed an online petition to a product have removed the schools.
Were able to choose the U.S. Department of Agriculture told school districts it in order to use the beef ingredient, and some dealers have to sell products that contain them, reports the AP.
The product is used for many years and meets standards for food safety, according to federal regulators. Critics say the product is an example of unattractive industrial food production.
-----
Human Gene Patents of U.S. Supreme Court lifted
Non-human genes can be patented, the U.S. Supreme Court said Monday, as it overturned a lower court to keep connected decision allowing a company, patents on two genes associated with an increased risk of breast and ovarian cancer.
Myriad Genetics Inc. of Salt Lake City, developed a test for mutations in the BRCA 1 and BRCA 2 genes does, the Associated Press reported.
The company patents on genes have been provided by the American Civil Liberties Union on behalf of a number of groups, including patients and geneticists in question.
In another case last week, the Supreme Court ruled that the laws of nature are not patentable, reports the AP.
-----
Deal reached on medical isotopes
An agreement to keep the supply of medical isotopes without the use of highly enriched uranium from the United States and some European countries has been achieved, President Barack Obama announced on Monday.
Medical isotopes are used worldwide to treat cancer and heart disease. Scientists have worked to create medical isotopes with low-enriched uranium instead of highly enriched uranium, which can be used to create nuclear weapons may be, the Associated Press reported.
The U.S. deal with Belgium, France and the Netherlands has been achieved in the context of a nuclear security summit in Seoul, South Korea.
World leaders at the summit to try to find ways to improve nuclear safety, reports the AP.